Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Keratoconjunctivitis Sicca

• Efficacy of a New Nanoemulsion Artificial Tear in Dry Eye Disease Management
• Safety and Efficacy of ST-100 (Vezocolmitide) Ophthalmic Solution 60 μg/ml Ophthalmic Solution in Subjects Diagnosed With Dry Eye Disease (DED)
• Evaluation of Miebo (Perfluorohexyloctane) Eyedrops in Habitual Contact Lens Wearers
• Effectiveness of Diquafosol Prophylactic Therapy to Prevent Dry Eye Disease for Cataract Surgery Patients in Indonesia
• Traditional Chinese Medicine Ultrasonic Atomization Treatment for Dry Eye Disease
• A Study to Assess the Safety and Efficacy of IC265 Ophthalmic Solution for Dry Eye in Adult Participants
• Improving Drop Instillation Comfort of a Cyclosporine A Solution
• Safety and Efficacy of Licaminlimab Ophthalmic Suspension for the Treatment of Dry Eye Disease
• Intra-Nasal Mechanical Stimulation (INMEST) as a Treatment Method for the Relief of Symptoms of Dry Eye
• A Study to Assess Symptom Relief and Product Tolerability of ABBV-444 Drops in Adult Participants
• Diamond Bur Microblepharoexfoliation, Intense Pulse Light and Meibomian Gland Expression for Evaporative Dry Eye
• Efficacy and Safety Evaluation of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye
• Efficacy and Safety of SHR8028 Eye Drops for the Treatment of Dry Eye Disease
• OTX-DED for the Short-term Treatment of the Symptoms of Dry Eye Disease (DED)
• Therapeutic Effect of Stem Cell Eye Drops on Dry Eye Disease
• The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease
• A Study of TL-925 as a Treatment for Dry Eye Disease
• HU007 in Patients With Dry Eye Syndrome
• Safety and Efficacy of Pluripotent Stem Cell-derived Mesenchymal Stem Cell Exosome (PSC-MSC-Exo) Eye Drops Treatment for Dry Eye Diseases Post Refractive Surgery and Associated With Blepharospasm
• Phase II Clinical Trial to Evaluate the Efficacy and Safety of SCAI-001 Eye Drops in Patients With Dry Eye Disease
• Effects of NOV03 on the Tear Film
• Temperature on Evaporative Dry Eye
• Nasal Spray Study in Sjogren's Dry Eye Disease
• Assessment of the Safety and Efficacy of BRM421 Ophthalmic Solutions in Subjects With Dry Eye.
• Management of DE With IPL in Combination With DQS
• Clinical Trial To Determine The Effectiveness And Safety Of Topical Insulin In Dry Eye
• Diquafosol vs Hyaluronic Acid for Diabetic Dry Eye
• Evaluation of the Tolerability and Efficacy of CWT-f-002 Lubricant Eye Drops
• A Multi-Centre, Randomised, Controlled, Masked Phase 2 Study of the Safety and Efficacy of KIO-101 Ophthalmic Solution, Versus Vehicle Control in the Treatment of Dry Eye Disease in Patients With Autoimmune Disease
• Safety, Tolerability and Preliminary Efficacy of Tacrolimus-loaded Punctal Plug in Patients With Moderate to Severe Dry Eye Disease - Cohort B
• Treatment Regimens in Meibomian Gland Dysfunction
• Study of INV-102 Ophthalmic Solution in Adults With Moderate Symptomatic Dry Eye Disease
• Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of OC-01 in Adult Chinese With Dry Eye Disease
• Effect of SHR8058 on Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction
• A Randomized, Controlled, Double-masked, Investigator-initiated Trial to Evaluate Tear Film Quality and Stability in Subjects With Dry Eye Disease Using OC-01 (Varenicline Solution) Nasal Spray 0.03 mg as Compared to Vehicle Control Nasal Spray
• Lifitegrast 5% for the Treatment of Dry Eye In Habitual Soft Contact Lens Wearers
• Study Evaluating Techniques for Measuring Tear Production
• A Long-Term Safety Study Evaluating the Safety and Systemic Exposure of AR-15512
• Phase II Study of SHJ002 Sterile Ophthalmic Solution Compared With Placebo in Participants With Dry Eye Disease.
• Phase 2, Multi-center, Randomized, Double- Masked and Placebo-Controlled Study of YP-P10 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (ICECAP 1)
• Effect of ADDE on Tear Interferometry
• Metabolomic Profile in Dry Eye Syndrome Patients.
• Effect of Topical Antioxidants in Dry Eye Disease and Diabetic Retinopathy
• Impact of Vitamin D3 Supplementation in Non-Sjogren Dry Eye Patients With Low Serum Vitamin D Level
• A Clinical Trial to Evaluate the Safety and Efficacy of Rreproxalap in Adults With Dry Eye Disease
• A Study for Evaluation of the Efficacy and Safety of SI-614 Ophthalmic Solution in Patient With Dry Eye
• A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye Disease
• Clinical Trial to Evaluate the Efficacy and Safety of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease
• A Study of AG-80308 in Dry Eye Patients
• Double-masked Controlled Study of SY-201 Ophthalmic Solution in Subjects With Dry Eye Disease
• Study Evaluating the Safety and Efficacy of AR-15512 (COMET-3)
• Comparison of Two Types of Artificial Tears
• Comparing Efficacy and Safety of TJO-083 in Dry Eye Disease Patients
• Cyclosporine 0.1% / Loteprednol 0.2% Effect on Anterior Segment Normalization
• Herbal Medication to Treat Dry Eye in Peri/ Post-menopausal Women
• Safety Study of Tivanisiran to Treat Dry Eye
• Study Evaluating the Safety and Efficacy of AR-15512
• Evaluating the Efficacy and Safety of TJO-087 in Moderate to Severe Dry Eye Disease Patients
• Study of ST-100 as Treatment for Dry Eye Disease
• A Study to Evaluate the Safety, Tolerability, and Efficacy of A197 in Subjects With Dry Eye Disease
• Concentration of Ofloxacin Into the Aqueous Humour of Patients With Dry Eye Disease
• A Phase 3, Multi-Center Study Evaluating PL9643 in Patients With Dry Eye
• Use of 3% Diquafosol Topical Ophthalmic Solution for Diabetic Dry Eye
• OC-01 (Varenicline) Nasal Spray and Dry Eye Signs and Symptoms in Daily Disposable Contact Lens Wearers
• Efficacy and Safety of Topical Hydrocortisone on Signs and Symptoms of Dry Eye Associated to Meibomian Gland Dysfunction
• IIT Assessing OC-01Nasal Spray on Symptoms of DED Following CXL
• Study to Evaluate Safety and Efficacy of Cenegermin (Oxervate®) 20 mcg/mL vs Vehicle, in Patients With Sjogren's Dry Eye
• Study to Evaluate Safety and Efficacy of Oxervate® Ophthalmic Solution vs Vehicle in Severe Sjogren's Dry Eye Disease
• Microvascular and Inflammatory Responses of 0.05 Cyclosporine Eye Drop (II) in Treatment of Dry Eye
• Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream (4%, 6%, 8%)
• A Study to Assess the Efficacy and Safety of Tanfanercept (HL036) Ophthalmic Solution in Participants With Dry Eye
• An Exploratory Clinical Trial to Assess Safety and Tolerability in Subjects With Dry Eye Disease
• Investigator Initiated Study to Assess the Efficacy of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease Following Laser-assisted in Situ Keratomileusis (LASIK)
• The TRANQUILITY 2 Trial: A Phase 3 Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye Disease
• Investigator Initiated Study to Assess the Efficacy of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease Following Photorefractive Keratectomy (PRK)
• Efficacy of Xiidra in Dry Eye Disease After Collagen Cross Linking
• Evaluation of the Safety, Tolerability and Efficacy of iNexin™ for the Treatment of the Signs and Symptoms Associated With Dry Eye Disease
• [KSR-001-P02] Phase 2b/3 Study, Evaluate the Efficacy and Safety of KSR-001 in Patients With Dry Eye Syndrome
• Diquafosol Ophthalmic Solution for Dry Eye Symptoms
• A Clinical Trial to Assess Subjects With Dry Eye Disease.
• Corneal Thickness Changes in Patient Undergoing Dry Eye Managment
• Probiotic in Dry Eye Syndromes
• The DEPOT Study (Dry Eye Prescription Options for Therapy)
• ALY688 Ophthalmic Solution in Subjects With Dry Eye Disease
• Safety, Efficacy and Pharmacokinetics of CBT-006 in Patients With Meibomian Gland Dysfunction
• Treatment of Dry Eye Disease Using Pro-ocular™ - A Proof of Concept, Safety, and Efficacy Study
• Effects of Topical Insulin on Levels of Tear Inflammatory Mediators
• Evaluation Of Vision Recovery And Comfort Index In Patients With Borderline/Mild Dry Eyes Undergoing FLACS With Premium IOL
• Digital Device Users Who Are Treated With Systane Hydration PF
• CEQUA for Sjogren's Syndrome Dry Eye
• Tivanisiran for Dry Eye in Subjects With Sjögren's Syndrome
• Prospective, Randomized, Masked, Controlled Trial To Evaluate The Safety And Effectiveness Of The TearCare® System In The Treatment Of The Signs And Symptoms Of Dry Eye Disease (SAHARA)
• The Effects and Safety of 5% Lifitegrast Ophthalmic Solution in Subjects With Dry Eye Disease in Ocular Graft-versus-Host Disease
• Effect of Traditional Chinese Medicine on Basic Tear Secretion and Tear Cytokines in Patients With Dry Eye Disease
• A Clinical Trial to Evaluate the Clinical Efficacy of Cyclosporine 0.1% (Ikervis®) for Moderate to Severe Dry Eye Patients. (IKE-03-SWITCHING)
• Study to Assess Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of Palovarotene Ophthalmic Solution in Healthy Adult Subjects
• To Assess the Efficacy and Safety of OTX-DED for the Short-term Treatment of Signs and Symptoms of Dry Eye Disease
• A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Clinical Trial Evaluating the Safety of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease
• A Research Study to See How Well an Eye Drop, SURF-200 (0.02% and 0.04% Betamethasone Sodium Phosphate), Works, What Side Effects There Are, and to Compare it With Vehicle (Placebo) in Subjects Diagnosed With Dry Eye Disease and Experiencing An Epis
• A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease
• Topical Cyclosporine A for the Treatment of Dry Eye: A Randomized Clinical Study
• Comprehensive Study on Dry Eye and Ocular Surface Disease Prior and After Cataract Surgery
• Phase II Clinical Study to Evaluate the Efficacy of Multidose Lagricel® Ofteno Ophthalmic Solution as Treatment for Dry Eye Disease.
• Phase IV Clinical Study to Compare the Efficacy of the Ophthalmic Solution Humylub Ofteno® PF With Hyabak® and Lagricel Ofteno® PF as Treatment for Dry Eye.
• Comparison of Efficacy Between 100% Platelet-rich Plasma and 100% Serum Eye Drops in Dry Eye Disease
• Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of GLH8NDE in Patients With Dry Eye Disease
• The TRANQUILITY Trial: Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye Disease
• The Chronology of Lifitegrast Effect on Anterior Surface Rehabilitation (CLEAR) Study
• Study on Curative Effect and Mechanism of Acupuncture on Neuropathic Pain in Dry Eye Disease
• The Effect of 3% Diquafosol Ophthalmic Solution on Visual Display Terminal-associated Dry Eye
• Wireless Micropump in Dry Eye Patients
• Dextenza With ILUX for Treatment of MGD
• Safety and Efficacy of Two Different Concentrations (0.5% and 1%) of Progesterone Topical Gel Compared to Placebo in Patients Diagnosed With Moderate to Severe Dry Eye Syndrome
• A Study Evaluating HBM9036 Efficacy and Safety on Moderate to Severe Dry Eye
• Mesenchymal Stem Cell Therapy of Dry Eye Disease in Patients With Sjögren's Syndrome
• Effect of NOV03 on Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction (Mojave Study)
• Study of VVN001 Ophthalmic Solution in Dry Eye Disease
• Comparing Treatment of Dry Eye With Intracanlicular Dexamethasone, Restasis, and/or Lotemax
• Study to Evaluate the Efficacy and Safety of CKD-352
• Assess the Safety and Efficacy of CsA Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye Disease
• Study to Evaluate the Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED) (SDP-4-CS202)
• Pre-Surgical Ocular Surface Treatment With Intracanalicular Dexamethasone Insert And Effect On Intraocular Lens Measurement Accuracy
• Intracanalicular Dexamethasone Insert for the Treatment of Inflammation and Discomfort in Dry Eye Disease (DEcIDED)
• CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease in Subjects Who Completed CYS-004
• ESSENCE 2: CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)
• Tear Film Markers in Dry Eye Syndrome
• OSIG-eye Drops Treatment for Dry Eye Disease
• Safety and Efficacy of Dexamethasone Ophthalmic Insert (Dextenza®) in the Management of Clinically Significant Dry Eye
• A Phase 2b Study Evaluating the Safety and Efficacy of AR-15512 Ophthalmic Solution for the Treatment of Dry Eye Disease
• Efficacy and Safety of Ikervis Under Controlled Environmental Conditions Environment
• Oral Pilocarpine in the Treatment of the Dry Eye of Patients With Sjogrens Syndrome
• The Effect of Cyclosporin Before Cataract Surgery
• A Randomized Study of Smile Exercise for Dry Eye
• Lipiflow Treatment Alone vs. Lipiflow + Dextenza Treatment for Dry Eye Disease
• Xiidra vs. Xiidra + Dextenza Treatment for Dry Eye Disease
• Effect of Re-esterified Triglyceride (rTG) Form Omega-3 Supplements on Dry Eye Following Cataract Surgery
• Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye Disease
• A Study to Assess the Safety and Efficacy of ECF843 vs Vehicle in Subjects With Dry Eye Disease
• HU007 Eye Drops in Patients With Dry Eye Syndrome
• Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-CSI in Subjects With Dry Eye Disease.
• Effect of Cequa™ in Subjects With Dry Eye Disease
• Safety and Efficacy of BRM421 for Dry Eye Syndrome Treatment
• Effect of Cequa Treatment on Accuracy of Pre-operative Biometry & Higher Order Aberrations in Dry Eye Patients Undergoing Cataract Surgery
• Efficacy and Safety of PL9643 Ophthalmic Solution in Subjects With Dry Eye
• ACCURATE Study for Subjects With Dry Eyes
• Umbilical Cord Serum Versus Conventional Eyedrops
• Effect of UMSCs Derived Exosomes on Dry Eye in Patients With cGVHD
• Vehicle-Controlled Study of SkQ1 as Treatment for Dry-eye Syndrome
• Phase 1/2a Safety and Efficacy of ALY688 Ophthalmic Solution in Subjects With Dry Eye Disease
• Effect of Intraoperative Dexamethasone on Post-op Dry Eye
• Phase 3 Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
• Clinical Efficacy of Two Topical Dry Eye Drops for Central Corneal Stain Clearing Over 90 Days
• Effects of Supplementation With PUFAs and Antioxidants for Contact Lens Discomfort
• Dose Ranging Study to Assess the Efficacy and Safety of Voclosporin Ophthalmic Solution in Subjects With Dry Eye Syndrome
• 3-year Study in Dry Eye Disease Patients With Severe Keratitis Receiving Ikervis® (1mg/mL Ciclosporin)
• Long-Term Safety and Tolerability of NOV03 (Perfluorohexyloctane) in Subjects Who Completed Trial NVU-003 (Kalahari Study)
• Perfluorohexylcotane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction (Gobi Study)
• Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease
• Evaluating HA 0.15% Compared With Cyclosporine 0.05%, and Efficacy of Combination Therapy in Dry Eye Disease Patients
• Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests
• Liposomal Sirolimus in Dry Eye Disease
• Clinical Trial to Compare the Safety and Efficacy of Nanodrop®
• A Study Evaluating the Efficacy and Safety on Moderate to Severe Dry Eye
• Comparison of Tear Evaporation Rate With Systane Complete in Dry Eye and Non-Dry Eye
• A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease
• Clinical Trial to Evaluate the Safety and Tolerability of Lagricel® Ofteno Multi-dose Ophthalmic Solution
• Evaluating the Efficacy and Safety of OC-01 (Varenicline) Nasal Spray on Dry Eye Disease
• A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease
• The Effect of Combination of Vitamin A, Vitamin E, Sodium Hyaluronate 0.15% Eye Drop Compared With Sodium Hyaluronate 0.1% Eye Drop to Tear Film Stability and Conjunctival Goblet Cells Density in Patient With Non-Proliferative Diabetic Retinopathy (
• IVIG-eye Drops Treatment for Dry Eye Disease
• A Study to Evaluate Safety and Efficacy of rhNGF Eye Solution vs Vehicle in Patients With Moderate to Severe Dry Eye
• Levocarnitine for Dry Eye in Sjogren's Syndrome
• Effect of Lifitegrast 5% on Tear Film Markers
• Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-3
• Tavilermide Ophthalmic Solution for the Treatment of Dry Eye
• Evaluation of the Long Term Follow up of the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease
• A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Clinical Trial of Reproxalap to Assess the Safety and Efficacy in Subjects With Dry Eye Disease
• Clinical Efficacy of Topical Hydrocortisone 0.335% (Softacort®) in Patients With Chronic Dry Eye Disease and Associated Ocular Surface Inflammation
• Study to Evaluate the Safety and Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED)
• Effect of Preservative-free Low-dose Hyaluronic Acid-containing Salt Solution on Dry Eye Disease
• The RENEW Trial: A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Adaptive Phase 3 Clinical Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease
• Treatment With Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Aqueous Deficient Dry Eye Disease
• Clinical Trial to Evaluate the Chronic Efficacy of OC-01 Nasal Spray on Signs of Dry Eye Disease (The MYSTIC Study)
• Comparing Effect of Topical Tacrolimus 0.03% Versus Cyclosporine 0.05% in Dry Eyes of Secondary Sjogren Syndrome
• Study of TOP1630 for Dry Eye Syndrome
• Effects of RP101 in Post-menopausal Women With Dry Eye Syndrome
• Study of Brimonidine Tartrate Nanoemulsion Eye Drop Solution in the Treatment of Dry Eye Disease (DED)
• Autologous Plasma Treatment for Severe Dry Eye Patients
• Study of SkQ1 as Treatment for Dry-eye Syndrome
• Ocular Micro-vascular Research Base on Functional Slip Lamp Biomicroscopy
• Clinical Study to Investigate the Efficacy and Safety of SJP002 Ophthalmic Solution in Patients With Dry Eye Syndrome.
• Clinical Study to Investigate the Efficacy and Safety of Orally Administered SA001 in Patients With Dry Eye Syndrome.
• Safety and Tolerability of the Ophthalmic Gel PRO-165 Versus Artelac® Nightime Gel
• Efficacy Study of Ketorolac and HPMC to Treat Dry Eye
• Clinical Trial to Evaluate the Efficacy of OC-01 Nasal Spray on Goblet Cell and Meibomian Gland Stimulation (The IMPERIAL Study)
• Assess the Safety and Efficacy of CsA Ophthalmic Gel in Subjects With Dry Eye
• Effect of Topical Naltrexone Ophthalmic Solution on the Signs and Symptoms of Dry Eye in Diabetic Subjects
• A Multicenter Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfunction and Evaporative Dry Eye Disease (DED)
• Clinical Effects of Diquas-S for Patients With Dry Eye After Cataract Surgery
• Evaluation of the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease
• Clinical Trial to Evaluate the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The RAINIER Study)
• Crosslinked Hyaluronic Acid With Liposomes and Crocin in Dry Eye
• Safety and Efficacy of KPI-121 in Subjects With DED
• Comparison Between Rebamipide 2% Versus Autologous Serum
• A Study to Evaluate the Safety, Tolerability, Systemic Pharmacokinetics, and Pharmacodynamics of AXR-159 Ophthalmic Solution in Patients With Dry Eye Disease (DED)
• Ocular Tolerability of Voclosporin Ophthalmic Solution Versus Restasis® in Subjects With Dry Eye Disease
• A Study to Assess the Safety and Effectiveness of SJP-0035 for the Treatment of Patients With Dry Eye Disease
• Safety and Tolerability of PRO-087 Versus Xyel Ofteno® and Systane Ultra®, on the Ocular Surface of Healthy Subjects
• Safety and Tolerability of the Ophthalmic Gel PRO-167 Versus Corneregel® on Healthy Subjects.
• Study on Prevention and Treatment of Dry Eye in Patients Using Glaucoma Drops
• Efficacy and Safety of HU007 Eye Drops in Patients With Dry Eye Syndrome
• Clinical Trial to Evaluate the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The PEARL Study)
• Effect of Lifitegrast on Dry Eye Disease Signs and Symptoms
• Efficacy of Two Concentrations of Autologous Serum for the Treatment of Severe Dry Eye
• Use of 5.0% Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease in Contact Lens Wearers
• Dry Eye Disease Study With Brimonidine
• Effects of Xiidra on Closed Eye Tear Film Leukocytes in Dry Eye Disease
• A Multi-Center, Randomized, Double Masked, Parallel-Group, Vehicle-Controlled, Clinical Study to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease
• Corneal Tear Film Imaging of the Cornea Before and After Restasis Therapy
• Repository Corticotropin Injection in Keratoconjunctivitis Sicca
• Tear Lipid Layer Thickness With Emollient Eye Drops
• Perfluorohexyloctane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)
• Evaluate the Efficacy and Safety of LO2A Eye Drops for Symptomatic Improvement of Dry Eye in Patients With Sjögren's Syndrome
• Optimization of the Treatment of Dry Eye Disease Caused by Meibomian Gland Dysfunction
• CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)
• Clinical Efficacy of H.P. Acthar Gel 80 U/ml to Improve the Signs and Symptoms in Subjects With Dry Eye Disease
• Effect of IKERVIS® Eye Drops Once Daily on the Quality of Vision in Dry Eye Disease Patients With Severe Keratitis
• Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome
• Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Ultra Preservative Free (087LATAMFIV)
• Assessing Safety and Efficacy of DE-089 Ophthalmic Solution in Patients With Dry Eye Disease
• Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome
• Comparative Study of Rohto Dry-Aid® and Systane® Ultra in Patients With Dry Eye
• A Randomized, Double Masked, Clinical Study of Subjects With Dry Eye Syndrome
• Effect of Topical Azithromycin on Tear Film Thickness in Patients With Meibomian Gland Dysfunction
• Assessing the Safety and Efficacy of AVX-012 in Subjects With Mild-to-moderate Dry Eye Syndrome
• Walnut Shell Glasses Moxibustion for Dry Eye Syndrome
• HELIX, a Double-masked Study of SYL1001 in Patients With Moderate to Severe Dry Eye Disease (DED)
• Safety and Efficacy of TOP1630 for Dry Eye Syndrome
• Safety and Efficacy of BRM421 for Dry Eye Syndrome
• An 8-week Study to Evaluate Safety and Efficacy of NGF Eye Drops Solution Versus Vehicle in Patients With Dry Eye
• Comparison of the Clinical Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome
• Symptom Response in Normal and Dry Eye Patients Secondary to Application of a Menthol-Containing Eyedrop (Rohto® Hydra)
• Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
• Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome : ARISE-2
• Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
• Efficacy Comparison of Two Kinds of Treatment in Treating Dry Eye Caused by Meibomian Gland Dysfunction
• Efficacy and Safety Study of HU00701/HU007 Eye Drops in Patients With Dry Eye Syndrome
• A Two Comparator, Controlled Phase 3 Study in Patients With and Without Evaporative Dry Eye
• An Open-Label Extension of a Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca
• Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
• Study of the Pharmacodynamic Activity of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
• Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
• Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
• Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
• Assessment of the Efficacy of Ocular Dipyridamole in the Treatment of Dry Eye Symptomology in Subjects With Pterygium
• Study to Evaluate the Efficacy and Safety of CKD-350
• Effect of Nursing Care on Prevention of Dry Eye
• Evaluation of Tear Osmolarity Over Time With Sustained Use of Thera Tears Lubricating Drops
• Comparison of Autologous Serum Versus Preservative Free Artificial Tear
• Can Pregabalin Reduce the Frequency and Severity of Dry Eye Symptoms After Laser-assisted in Situ Keratomileusis?
• Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca
• A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye Disease
• A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye
• CyclASol for the Treatment of Moderate to Severe Dry-eye Disease (DED)
• Clinical Effects and Safety of 3% Diquafosol After Cataract Surgery
• Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-1
• 0.3% Sodium Hyaluronate in the Treatment of Dry Eye of Diabetic Patients
• Evaluation of Maintaining Visual Performance in Participants Who Engage in Electronic Visual Tasking While Using Restasis®
• A Safety and Efficacy Study of a New Eye Drop Formulation in Patients With Dry Eye Disease.
• Effect of Benzalkonium Chloride Containing Eye Drops on the Conjunctival Bacterial Flora of Dry Eye Patients
• A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome
• An Extension Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome
• A Long-term Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome
• Efficacy and Safety of HE10 for Dry Eye Syndrome
• Evaluation of Clinical Outcomes After the Use of SYSTANE® HYDRATION
• OTX-14-006: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Dry Eye
• Efficacy and Safety Study of TJCS for Treatment of Moderate to Severe Dry Eye Syndromes
• Dose-finding Study to Assess the Safety and Effect of SYL1001 in Patients With Ocular Pain
• A Study to Compare a New Eye Drop Formulation With Systane® Gel Drops and Genteal® Lubricant Gel Drops for Moderate to Severe Dry Eye Relief
• Clinical Evaluation Following Use of SYSTANE® ULTRA in the Management of Dry Eye
• Safety, Efficacy, Tolerability and Pharmacokinetics of AGN-223575 Ophthalmic Suspension in Patients With Dry Eye Disease
• Safety, Tolerability and Systemic Pharmacokinetics of AGN-232411 in Healthy Participants and Participants With Dry Eye
• Study of EBI-005 in Dry Eye Disease (DED)
• Paralysis of the Orbicularis Muscle of the Eye in the Treatment for Dry Eye
• Study of ST266 Eye Drops in Treating Dry Eye
• Phase 2 Study With Cis-UCA Ophthalmic Solutions in Subjects With Dry Eye
• A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)
• A Safety and Efficacy Study of Refresh Optive® Gel Drops in Patients With Dry Eye Disease
• Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry Eye
• Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca
• Study of the Safety and Tolerability of P 321 Ophthalmic Solution in Subjects With Dry Eye Disease
• Efficacy and Safety of XG-104 for the Treatment of Dry Eye
• Study of Tisporin Eye Drops Group and Restasis Eye Drops Group After Treatment, Each Treatment Group Comparisons for Evaluation of Efficacy and Safety in Moderate to Severe Dry Eye Disease
• Topical Steroid Treatment For Dry Eye
• A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye.
• The Effects of Cyclosporin A in a Low Humidity Environment, on the Ocular Surface
• DNase Treatment for Dry Eyes
• Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
• Evaluation of Therapeutic Effect of Bandage Contact Lenses ( BCL) on Dry Eye Caused by Sjogren's Syndrome
• A Phase 4 Study Investigating the Efficacy of Retaine™ in Managing Signs and Symptoms Associated With Dry Eye Syndrome
• Dry Eye Assessment and Management Study
• Investigation of Maintaining Visual Performance Achieved With Cyclosporine Therapy
• A Clinical Study to Assess the Safety and Efficacy of an Ophthalmic Solution (SkQ1) in the Treatment of Dry Eye Syndrome (DES)
• The Utility of IVCM to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With DED
• A Safety and Efficacy Study of OPTIVE FUSION™ With VISMED® Multi for the Management of Dry Eye
• Civamide Nasal Solution for the Treatment of Dry Eye
• The Utility of IVCM to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With DED
• Safety and Efficacy of rhNGF Eye Drops at Different Doses in Patients With Dry Eye
• Phase 2 Study to Evaluation the Safety and Efficacy of Orally Administered KL7016 in Patients With Dry Eye Syndrome
• Safety and Efficacy of PG101 for Dry Eye Syndrome
• Efficacy and Safety of Fluorometholone (FML) in Dry Eye Disease (Keratoconjunctivitis Sicca)
• Safety and Efficacy Study of R932348 Ophthalmic Solution in Chronic Ocular Graft Versus Host Disease Patients(DROPS-2)
• A Study of Sodium Carboxymethylcellulose for Post Cataract Surgery Dry Eye Symptoms
• A Phase IV, Randomized, Parallel Group, Investigator-Masked Evaluation of the Effect of Loteprednol Etabonate Ophthalmic Gel 0.5% on the Initiation of Dry Eye Treatment With Restasis®
• A Study to Determine the Relief of Dry Eye Symptoms With the Use of TheraTears® Products (DUNLIN)
• Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease
• Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease
• Phase 3 Study of EBI-005 in Dry Eye Disease
• Clinical Outcomes Following Treatment With Systane® Balance in Dry Eye Subjects
• A Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye
• To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
• A Late Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes
• Dry Eye Disease in the Vitamin D and Omega-3 Trial (VITAL)
• Treatment of Dry Eye Using 0.03% Tacrolimus Eye Drops
• Lotemax® Gel 0.5% and Restasis 0.05% in Participants With Mild or Moderate Keratoconjunctivitis Sicca (Dry Eye Disease)
• Efficacy and Safety Study of Haporine-S for Treatment of Moderate to Severe Dry Eye Syndromes
• Effects of Dry Eye Treatments on the Ocular Surface
• Pilot Study to Evaluate SYL1001 Safety and Effect in Patients With Ocular Pain
• Systane Ultra Versus Maxidex Versus Saline
• Study of Cyclosporine Ophthalmic Soution Group and Cyclosporine Ophthalmic Suspension Group
• Evaluation of the Corneal Residence Time of Chitosan-N-acetylcysteine Eye Drops in Patients With Dry Eye Syndrome After Single and Multiple Instillation
• A Multi-Center Study Subjects With Dry Eye Syndrome
• A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
• A Safety, Tolerability and Pharmacokinetics Study of R932348 Eye Drops in Patients With Dry Eye Disease
• An Observational Study of OPTIVE PLUS® for the Treatment of Dry Eye Disease
• A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes
• Pilot Study on the Use of Artificial Tears to Treat Dry Eye in Glaucoma Patients
• A Study of RX-10045 in the Treatment of Dry Eye Disease
• Phase II Study of DA-6034 Eye Drops in Dry Eye Syndrome
• A Study to Compare the Safety and Efficacy of A New Eye Drop Formulation With OPTIVE™ in Subjects With Dry Eye Disease
• Confirmatory Study of OPC-12759 Ophthalmic Solution
• Efficacy and Safety of PRO-148 Versus Systane®, in Patients With Mild to Moderate Dry Eye
• Evaluation of Ocular Comfort With ISTA Tears vs Systane
• Safety Study of Lifitegrast to Treat Dry Eye
• Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
• Hydroxychloroquine Treatment of Dry Eyes in Patients With Primary Sjögren's Syndrome
• The Effect of Intravenous Glucocorticoids on the Tearfilm in Eyes With Thyroid-associated Ophthalmopathy
• Efficacy of Nonsteroidal Anti-inflammatory Drugs in Treatment of Moderate and Severe Dry Eye Disease
• A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye
• Efficacy and Safety of PRO-148 Ophthalmic Solution Versus SYSTANE® in the Treatment of Patients With Dry Eye Syndrome
• A Dose-Finding Study Comparing InSite Vision, Inc. 101 to Vehicle and DuraSite Alone for Dry Eye Disease
• Safety Study of OPC-12759 Ophthalmic Solution
• A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
• Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease
• A Phase II Study of KCT-0809 in Patients With Dry Eye Syndrome
• Safety and Efficacy Study of SAR 1118 to Treat Dry Eye Conducted in a Controlled Adverse Environment (CAE) (OPUS-1)
• Comparative Study of Thymosin Beta 4 Eye Drops vs. Vehicle in the Treatment of Severe Dry Eye
• Safety and Efficacy of Thymosin Beta 4 Ophthalmic Solution in Patients With Dry Eye
• Efficacy of FreshKote and Systane for the Treatment of Dry Eye and Improvement of Osmolarity
• Efficacy of the Chronic Application of Tear Formulations
• Altaire Gel Forming Solution Versus Refresh Tears for the Treatment of Dry Eye Signs and Symptoms
• Sodium Hyaluronate Ophthalmic Solution, 0.18% for Treatment of Dry Eye Syndrome
• Sodium Hyaluronate and Wavefront Aberrations in Dry Eyes
• Study of Two Formulations of Cyclosporine Ophthalmic Emulsion in Healthy Volunteers and in Patients With Dry Eye
• Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye Disease
• The Effects of BAK on the Blood Aqueous Barrier of Pseudophakic Patients
• Evaluation of Anti-Inflammatory Treatment in Dry Eye Patients
• The Effect of Ocular Lubricant Eyedrops on Lid Parallel Conjunctival Folds and Other Signs and Symptoms of Dry Eye
• Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye
• Phase III Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
• Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
• Trial of CF101 to Treat Patients With Dry Eye Disease
• A Study Of Tasocitinib In Dry Eye Subjects
• A Dose Ranging Study to Evaluate Safety and Efficacy of Bromfenac Ophthalmic Solution in Dry Eye Disease
• A Study of KCT-0809 in Patients With Dry Eye Syndromes
• Evaluation of the Effect and Tolerance of Preservative Free NAAGA on the Inflammatory Component and Symptoms of Dry Eye Syndrome in Allergic Conjunctivitis Patients
• Late Phase II Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
• Study to Assess the Safety and Efficacy of BOL-303242-X Ophthalmic Suspension in Dry Eye Syndrome
• Phase I Study to Evaluate the Tolerability of Eye Drop DA-6034 in Healthy Volunteers
• A Phase II, Dose Ranging Study Of CP-690,550 Eye Drops In Patients With Dry Eye Disease
• Safety and Efficacy Study of EGP-437 (Dexamethasone Phosphate Formulated for Ocular Iontophoresis) to Treat Dry Eye
• Non-invasive Tear Film Dynamic Measurements in Normal, MGD and ADDE Subjects After Saline Instillation
• Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
• Oral Omega-3 Fatty Acids in the Treatment of Dry Eye Syndrome
• A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Rewetting Drops in Subjects With History and Current Complaint of Contact Lens-Related Dry Eye (CLDE)
• Acupuncture for Dry Eye
• Dry Eye Assessment and Management: Feasibility Study
• Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
• Pilot Study of a Homeopathic Therapy in Combination With Cyclosporin (Restasis) in the Treatment of Dry Eye Disease
• A Clinical Evaluation Pilot Study of the Efficacy of Blink® Tears Lubricant Eye Drops for the Relief of Dry Eye Symptoms Following Implantation of Tecnis® Multifocal Introcular Lens
• Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Subjects With Dry Eye - Effects on Central Cornea
• Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Patients With Dry Eye
• A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Dry Eye Disease
• The Effect of a New Emulsion in Dry Eye Patients on Tear Layer Aberrometry, Contrast Sensitivity, and Reading Ability
• Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects
• Safety and Efficacy of Carboxymethylcellulose for Ocular Surface Integrity in Symptomatic Dry Eye
• Study to Compare the Efficacy and Safety of Two Non-Preserved Artificial Tears for the Treatment of Dry Eye Signs and Symptoms
• Safety and Tolerability of Artificial Tears in Dry Eye Subjects
• A Study Evaluating the Efficacy of SAR 1118 (0.1%, 1.0%, 5.0%) Ophthalmic Solution in Subjects With Dry Eye Conducted in a Controlled Adverse Environment (CAE)
• Efficacy, Tolerability, and Comfort of 0.3% Hypromellose Eyedrops in Patients Undergoing LASIK Surgery
• A Study of AL-38583 Ophthalmic Solution 0.05%, 0.010% Versus AL-38583 Vehicle for Dry Eye
• Confirmatory Study of OPC-12759 Ophthalmic Suspension
• A Dose-Escalation Study to Assess the Safety and Tolerability of LX214 Ophthalmic Solution in Healthy Volunteers, Followed by an Open-Label Evaluation of LX214 in Patients With Keratoconjunctivitis Sicca (KCS)
• A Study of Hydroxypropyl Guar Galactomannan 0.25% (HPGG) Versus Vehicle in Dry Eye Patients
• The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease (P08637)
• Physician's Evaluation of Cyclosporine Ophthalmic Emulsion 0.05%
• Long Term Administration Study of OPC-12759 Ophthalmic Suspension
• A Dose-Ranging Clinical Study to Assess the Safety and Efficacy of Subconjunctival Injection of Sirolimus in Patients With Dry Eye in the Controlled Adverse Environmental (CAE) Model
• Double-Masked Trial of NOVA22007 (Ciclosporin 0.1%) Versus Vehicle in Patients With Moderate to Severe Dry Eye Syndrome
• Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z®
• Safety and Efficacy Study of RX-10045 on the Signs and Symptoms of Dry Eye
• Topical Cyclosporine for the Treatment of Dry Eye in Patients Infected With the Human Immunodeficiency Virus
• Efficacy and Safety Study of ATs in Patients With Dry Eye Syndrome
• A Prospective, Randomized, Placebo and Active Comparator Controlled Study of CP-690,550 in Subjects With Dry Eye.
• Autologous Serum Efficacy Study in Patients With Severe Dry Eye
• Safety and Efficacy Study of Iontophoresis and Dexamethasone Phosphate to Treat Dry Eye
• Performance and Acceptance of Optive Versus Hylocomod Eyedrops in Patients With Dry Eye Symptoms
• Clinical Pharmacological Study of AL-43546 Ophthalmic Product in Subjects With Shortened Tear Film Break Up Time
• Safety and Efficacy of an Ophthalmic Solution in Dry Eye Disease
• Efficacy and Acceptability of Two Lubricant Eye Drops
• NOVA22007 0.05% and 0.1% Cyclosporine Versus Vehicle for the Treatment of Dry Eye
• Phase 2 Study of KLS-0611 in Patients With Dry Eye Syndromes
• Efficacy Study of Cyclosporine Ophthalmic Emulsion in Patients With Dry Eye Disease
• Comparison of Efficacy, Safety and Anti-Inflammatory Effect Between Topical 0.05%Cyclosporine A Emulsion and REFRESH® in Patients With Moderate to Severe Dry Eyes
• Tear Film Break-up Time After Instillation of Artificial Tears
• A Study to Determine the Safety and Tolerability of Escalating Doses of INS365 Ophthalmic Solution
• A Study of INS365 Ophthalmic Solution in Patients With Moderate to Severe Dry Eye Disease
• Efficacy Study of Ecabet Ophthalmic Solution in Dry Eye Disease
• Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality
• Bilateral, Masked Comparison of PEG-400 Based Artificial Tear vs. Systane for Dry Eye Signs, Symptoms & Refractive Regression Associated With Myopic Laser in Situ Keratomilieusis (LASIK).
• Safety and Efficacy Study of Cyclosporine Ophthalmic Emulsion in Post-LASIK Patients
• Tear Film Stability After Instillation of Over-the-Counter (OTC) Artificial Drops
• Artificial Tears Study in Mild to Moderate Dry Eye Patients
• Study of the Effect of Diquafosol Tetrasodium Ophthalmic Solution, 2% Versus Placebo in Dry Eye Subjects (P08634)
• Safety and Efficacy Assessment of Vismed® (Sodium Hyaluronate) for the Treatment of Dry Eye Syndrome
• Objective Measurements of Prolonged Effects of Restasis on Dry Eye Disease
• Evaluation of Blink Tears and Systane Concomitant With Restasis for the Treatment of Dry Eye Symptoms
• Loteprednol Etabonate Opthalmic Suspension for the Treatment of Dry Eye
• The Prophylactic Use of Topical Cyclosporine A 0.05% to Prevent Graft Versus Host Disease Related Dry Eye
• Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-006)
• Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-007)
• Evaluate the Safety and Efficacy of a New Artificial Tear for Use After LASIK Surgery
• Study to Assess the Safety and Patients' Satisfaction of Tears Again* in the Treatment of Dry Eye Symptoms
• Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase
• Safety and Efficacy of an Artificial Tear for the Treatment of Dry Eye
• Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-005)
• Late Phase 2 Study of OPC-12759 Ophthalmic Suspension
• Phase II Study of AL-2178 (FID 109980) in the Treatment of Dry Eye
• Safety and Efficacy of Optive in Contact Lens Wearers With Dry Eyes
• Refractive Surgery and Optive Compatibility Study
• Comparison of Autologous Serum and Umbilical Cord Serum Eyedrops for Dry Eye Syndrome
• A Study of ALTY-0501 for the Treatment of Dry Eye Administered 4 Times a Day for a 56 Day Period
• Effect of B-cell Depletion in Patients With Primary Sjögren's Syndrome
• Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With Restasis
• Efficacy and Safety of a New Multi-dose Lubricant Eye Drop Concomitant With Restasis® (Cyclosporine A) for the Treatment of Dry Eye Symptoms
• Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease
• Study of Diquafosol Tetrasodium Ophthalmic Solution in Subjects With Dry Eye Disease
• Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease
• A Comparison of Optive in Patients Previously Using Systane for the Treatment of Dry Eye
• Efficacy of Optive Versus Systane Concomitant With Restasis (Cyclosporine A) for the Treatment of Dry Eye Symptoms
• The Visual Effect of an Investigational Artificial Tear in the Tear Layer.
• Comparison of Systane Free vs. Saline in the Treatment of Dry Eye
• Comparative Study of 0.5% Carboxymethylcellulose With 0.005% Stabilized Oxychlorocomplex (PURITE™) Versus 0.5% Carboxymethylcellulose in the Treatment of Dry Eye
• Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome
• Efficacy of T1675 Versus Placebo in Patients With Bilateral Treated Moderate Dry Eye Syndrome
• A Prospective Clinical Study Assessing the Effects of Tetracycline Antibiotic on Tear Film and Tear Lipid Composition Within a Population of Patients Diagnosed With Blepharitis and Dry Eye Disease
• Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis Sicca
• Efficacy of Cyclosporine for the Prevention and Treatment of Dry Eye Symptoms Following LASIK or Photorefractive Keratectomy
• Effects of Systane Versus Saline in Maintaining Tear Film Stability at Determined Time Points
• A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome
• Efficacy of Cyclosporine Ophthalmic Emulsion in the Treatment of Dry Eye Syndrome in Contact Lens Wearers
• Soothe Versus Refresh
• Dose-response Study of OPC-12759 Ophthalmic Suspension
• Study of Rebamipide Eye Drops to Treat Dry Eye
• Study of Rebamipide Eye Drops to Treat Dry Eye
• Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome
• Safety and Efficacy of Pimecrolimus Ophthalmic Suspension in Patients With Moderate to Severe Keratoconjunctivitis Sicca
• Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye
• Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome
• Treatment of Dry Eye Syndrome With Cyclosporin A Eye Drops